Anticancer drug ellipticine forms DNA adducts in vivo; A novel mode of its antineoplatic action

Abstract

Anticancer drug ellipticine forms DNA adducts in vivo; A novel mode of its antineoplatic action

Keywords

• ANTICANCER DRUG
• ELLIPTICINE
• DNA ADDUCTS
• IN VIVO
• 32P-postlabeling
• cytochrome P450 (CYP)
• CYP1A1/2